Coronavirus vaccine update: COVID-19 vaccine could arrive by early 2021, delivery still an issue, feels ICMR scientist


Kang, who works as microbiology professor earlier had also said thatinfrastructural hurdles also need to be worked out to store the millions of doses which shall be made ready in the coming months.

From the Oxford vaccine to the Russian one, and the homegrown vaccines currently in phase II/III of development, experts have suggested that we will see anywhere between 100-300 million doses in the first six months of 2020.

“It takes time to make a vaccine and the reason why vaccine manufacturers are now trying to buy facilities, book time at the manufacturing facilities, is because they want to be able to make the vaccine even before it is proven safe and effective…That is the fastest way to get to the market but the whole process of regulation takes time. It will take time to review the dossiers, it will take time to get the vaccine licensed, and once the vaccine is licensed we have to think about the logistics of distribution… You need something that fits in with your cold chain infrastructure, you need to be able to buy the vaccine, you need to land the vaccine, you need to distribute the vaccine, you need to train staff in how to give the vaccine.”


Please enter your comment!
Please enter your name here

Enable Google Transliteration.(To type in English, press Ctrl+g)